FDA clears IBA patient positioning system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Ion Beam Applications (IBA) has received FDA clearance for a new robotic patient positioning system (PPS) for proton therapy.

ProCure Treatment Centers of Bloomington, Ind., and IBA of Louvain-La-Neuve, Belgium, developed the PPS, in collaboration with Forte Automation Systems of Rockford, Ill. The first clinical installation will be at the ProCure Proton Therapy Center in Oklahoma City, scheduled to open this summer.

"In the use of proton therapy and other forms of radiation therapy for cancer treatment, the movement of the patient must be precisely controlled to accurately target the tumor in order to achieve the maximum therapeutic dose and avoid harm to healthy tissues surrounding the tumor," said Niek Schreuder, senior vice president of medical physics and technology of ProCure.

The company said the basic configuration of the robotic PPS is a Selective Compliant Assembly Robot Arm, combining commercially available robotic sub-systems with custom designed arms to allow for the needs of patient positioning in proton therapy. A dual-coupler system is attached at the end of the wrist of the robot arm that is used to attach different devices to the PPS, such as a patient table or chair or a test phantom.